222 related articles for article (PubMed ID: 8566137)
21. Pharmacology of LR-B/057, a novel orally active AT1 receptor antagonist.
Renzetti AR; Cucchi P; Guelfi M; Cirillo R; Salimbeni A; Subissi A; Giachetti A
J Cardiovasc Pharmacol; 1995 Mar; 25(3):354-60. PubMed ID: 7769798
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277.
Wienen W; Hauel N; Van Meel JC; Narr B; Ries U; Entzeroth M
Br J Pharmacol; 1993 Sep; 110(1):245-52. PubMed ID: 8220885
[TBL] [Abstract][Full Text] [Related]
23. The angiotensin hexapeptide 3-8 fragment potently inhibits [125I]angiotensin II binding to non-AT1 or -AT2 recognition sites in bovine adrenal cortex.
Jarvis MF; Gessner GW; Ly CQ
Eur J Pharmacol; 1992 Aug; 219(2):319-22. PubMed ID: 1425957
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo pharmacology of olmesartan medoxomil, an angiotensin II type AT1 receptor antagonist.
Koike H; Sada T; Mizuno M
J Hypertens Suppl; 2001 Jun; 19(1):S3-14. PubMed ID: 11451212
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation.
Virone-Oddos A; Desangle V; Provost D; Cazes M; Caussade F; Cloarec A
Br J Pharmacol; 1997 Feb; 120(3):488-94. PubMed ID: 9031754
[TBL] [Abstract][Full Text] [Related]
26. In vitro pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonist.
Caussade F; Virone-Oddos A; Delchambre C; Cazes M; Versigny A; Cloarec A
Fundam Clin Pharmacol; 1995; 9(2):119-28. PubMed ID: 7628824
[TBL] [Abstract][Full Text] [Related]
27. Pharmacology of LR-B/081, a new highly potent, selective and orally active, nonpeptide angiotensin II AT1 receptor antagonist.
Cirillo R; Renzetti AR; Cucchi P; Guelfi M; Salimbeni A; Caliari S; Castellucci A; Evangelista S; Subissi A; Giachetti A
Br J Pharmacol; 1995 Mar; 114(6):1117-24. PubMed ID: 7620700
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of a novel angiotensin II type 1 receptor antagonist RNH-6270 on growth of vascular smooth muscle cells from spontaneously hypertensive rats: different anti-proliferative effect to angiotensin-converting enzyme inhibitor.
Teng J; Fukuda N; Suzuki R; Takagi H; Ikeda Y; Tahira Y; Kanmatsuse K
J Cardiovasc Pharmacol; 2002 Feb; 39(2):161-71. PubMed ID: 11791001
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological and pharmacokinetic evaluation of EXP3312, an orally-active non-peptide angiotensin II-receptor antagonist.
Wong YN; Wong PC
J Pharm Pharmacol; 1996 May; 48(5):492-7. PubMed ID: 8799873
[TBL] [Abstract][Full Text] [Related]
30. [125I]EXP985: a highly potent and specific nonpeptide radioligand antagonist for the AT1 angiotensin receptor.
Chiu AT; McCall DE; Roscoe WA
Biochem Biophys Res Commun; 1992 Nov; 188(3):1030-9. PubMed ID: 1445340
[TBL] [Abstract][Full Text] [Related]
31. Pharmacologic characterization of CI-996, a new angiotensin receptor antagonist.
Keiser JA; Ryan MJ; Panek RL; Hodges JC; Sircar I
J Pharmacol Exp Ther; 1995 Mar; 272(3):963-9. PubMed ID: 7891350
[TBL] [Abstract][Full Text] [Related]
32. Nonpeptide angiotensin II receptor antagonist recognizes inter-species differences in angiotensin AT1 receptors.
Kawano K; Fujishima K; Nagura J; Yasuda S; Shinki ; Hachisu M; Konno F
Eur J Pharmacol; 1998 Sep; 357(1):33-9. PubMed ID: 9788771
[TBL] [Abstract][Full Text] [Related]
33. Pharmacology and pharmacokinetics of a novel nonpeptide angiotensin II receptor antagonist--DMP 811.
Wong PC; Huang SM; Ardecky RJ; Carini DJ; Chiu AT; Price WA; Agra AM; Wexler RR; Timmermans PB
Clin Exp Hypertens; 1995 Nov; 17(8):1233-56. PubMed ID: 8563699
[TBL] [Abstract][Full Text] [Related]
34. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
Wienen W; Mauz AB; Van Meel JC; Entzeroth M
Mol Pharmacol; 1992 Jun; 41(6):1081-8. PubMed ID: 1614410
[TBL] [Abstract][Full Text] [Related]
35. Pharmacology of SC-52458, an orally active, nonpeptide angiotensin AT1 receptor antagonist.
Olins GM; Corpus VM; Chen ST; McMahon EG; Palomo MA; McGraw DE; Smits GJ; Null CL; Brown MA; Bittner SE
J Cardiovasc Pharmacol; 1993 Oct; 22(4):617-25. PubMed ID: 7505365
[TBL] [Abstract][Full Text] [Related]
36. Candesartan (CV-11974) dissociates slowly from the angiotensin AT1 receptor.
Ojima M; Inada Y; Shibouta Y; Wada T; Sanada T; Kubo K; Nishikawa K
Eur J Pharmacol; 1997 Jan; 319(1):137-46. PubMed ID: 9030909
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566.
Edwards RM; Aiyar N; Ohlstein EH; Weidley EF; Griffin E; Ezekiel M; Keenan RM; Ruffolo RR; Weinstock J
J Pharmacol Exp Ther; 1992 Jan; 260(1):175-81. PubMed ID: 1309870
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of rabbit aortic angiotensin II (AII) receptor by CV-11974, a new nonpeptide AII antagonist.
Noda M; Shibouta Y; Inada Y; Ojima M; Wada T; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
Biochem Pharmacol; 1993 Jul; 46(2):311-8. PubMed ID: 8347154
[TBL] [Abstract][Full Text] [Related]
39. Characterization of contractile response to angiotensin in epididymal rat vas deferens.
Sum CS; Cheung WT
Pharmacology; 1995 Aug; 51(2):105-11. PubMed ID: 8584570
[TBL] [Abstract][Full Text] [Related]
40. In vitro pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for AT2 receptors.
Chang RS; Lotti VJ; Chen TB; O'Malley SS; Bendesky RJ; Kling PJ; Kivlighn SD; Siegl PK; Ondeyka D; Greenlee WJ
Eur J Pharmacol; 1995 Dec; 294(2-3):429-37. PubMed ID: 8750703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
